Edition:
United States

Kindred Biosciences Inc (KIN.OQ)

KIN.OQ on NASDAQ Stock Exchange Capital Market

8.15USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$8.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
19,476
52-wk High
$9.60
52-wk Low
$4.20

Chart for

About

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company. The Company is focused on developing therapies for pets. The Company's product pipeline consists of small molecules and biologics for a range of indications in dogs, cats and horses. The Company is developing product candidates for over 20 indications... (more)

Overall

Beta: 0.18
Market Cap(Mil.): $226.88
Shares Outstanding(Mil.): 27.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-KindredBio Announces Positive Results From Pivotal Study Of Zimeta Oral

* KINDREDBIO ANNOUNCES POSITIVE RESULTS FROM PIVOTAL STUDY OF ZIMETA ORAL FOR FEVER IN HORSES

Dec 04 2017

BRIEF-Kindred Biosciences posts Q3 loss of $0.29 per share

* Kindred biosciences announces third quarter 2017 financial results

Nov 07 2017

BRIEF-Kindred Biosciences Q2 loss per share $0.29

* Kindred Biosciences announces second quarter 2017 financial results

Aug 07 2017

BRIEF-Kindredbio announces proposed public offering of common stock

* Kindredbio announces proposed public offering of common stock

Jul 11 2017

Earnings vs. Estimates